Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
The most common reactions were that 3.7 percent of participants experiencing fatigue and 2 percent had a headache, it said.
Pfizer has developed a super-cool storage unit packed with dry ice, which it says will help transport the vaccine around the world, including to remote places. But experts warn that in practice keeping such a vaccine at such low temperatures will be an unprecedented supply-chain challenge.